Lanean...

Obinutuzumab for the treatment of patients with previously untreated chronic lymphocytic leukemia: overview and perspective

Chronic lymphocytic leukemia (CLL) is the most common lymphoproliferative disorder in the Western world and predominantly affects older people. Until recently, most studies in CLL focused on younger patients in whom intensive therapy with the addition of rituximab to fludarabine and cyclophosphamide...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Ther Adv Hematol
Egile Nagusiak: Owen, Carolyn J., Stewart, Douglas A.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: SAGE Publications 2015
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4530370/
https://ncbi.nlm.nih.gov/pubmed/26288711
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2040620715586528
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!